ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $43,000 | +4.9% | 10,000 | 0.0% | 0.00% | – |
Q3 2020 | $41,000 | +105.0% | 10,000 | +41.0% | 0.00% | – |
Q1 2020 | $20,000 | -76.2% | 7,091 | -68.2% | 0.00% | – |
Q4 2019 | $84,000 | -10.6% | 22,279 | +21.5% | 0.00% | – |
Q3 2019 | $94,000 | -18.3% | 18,341 | -1.0% | 0.00% | – |
Q2 2019 | $115,000 | -8.7% | 18,533 | +4.8% | 0.00% | – |
Q1 2019 | $126,000 | -91.5% | 17,692 | -89.8% | 0.00% | -100.0% |
Q4 2018 | $1,479,000 | -26.5% | 173,179 | +72.4% | 0.00% | -50.0% |
Q3 2018 | $2,012,000 | +16.1% | 100,478 | +49.7% | 0.00% | 0.0% |
Q2 2018 | $1,733,000 | -23.9% | 67,112 | -29.6% | 0.00% | 0.0% |
Q1 2018 | $2,277,000 | -52.2% | 95,302 | -32.2% | 0.00% | -50.0% |
Q4 2017 | $4,766,000 | +1000.7% | 140,649 | +587.8% | 0.00% | – |
Q3 2017 | $433,000 | +21550.0% | 20,449 | +20766.3% | 0.00% | – |
Q2 2017 | $2,000 | – | 98 | +9700.0% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
Q3 2016 | $5,000 | -90.7% | 299 | -91.6% | 0.00% | – |
Q2 2016 | $54,000 | -73.5% | 3,555 | -74.9% | 0.00% | – |
Q1 2016 | $204,000 | +5.7% | 14,151 | +107.9% | 0.00% | – |
Q4 2015 | $193,000 | +1508.3% | 6,806 | +819.7% | 0.00% | – |
Q3 2015 | $12,000 | -91.2% | 740 | -85.7% | 0.00% | – |
Q2 2015 | $136,000 | +338.7% | 5,191 | +190.2% | 0.00% | – |
Q1 2015 | $31,000 | +19.2% | 1,789 | +20.0% | 0.00% | – |
Q4 2014 | $26,000 | +1200.0% | 1,491 | +1333.7% | 0.00% | – |
Q3 2014 | $2,000 | +100.0% | 104 | +62.5% | 0.00% | – |
Q2 2014 | $1,000 | – | 64 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|